1196-22-1

Usage

Uses

Used in Fragrance Industry:
2-methyl-6-oxocyclopent-1-enyl acetate is used as a perfume ingredient for its ability to impart a sweet, fruity, and floral scent to fragrances, enhancing their appeal and longevity.
Used in Food and Beverage Industry:
In the food and beverage sector, 2-methyl-6-oxocyclopent-1-enyl acetate is used as a flavoring agent to add a subtle sweet and fruity note to various products, thereby enriching their taste profiles.
Used in Health and Wellness Applications:
2-methyl-6-oxocyclopent-1-enyl acetate is studied for its potential health benefits, such as its anti-inflammatory and anti-cancer properties, indicating its possible use in pharmaceutical or nutraceutical products for promoting health and well-being.

Upstream product

• 765-70-8 3-methyl-1,2-cyclopentanedione 
• 108-24-7 acetic anhydride 
• 75-36-5 acetyl chloride 
• 67-47-0 5-hydroxymethyl-2-furfuraldehyde 
• 80-71-7 2-hydroxy-3-methylcyclopent-2-en-1-one 

Downstream Products

• 214557-51-4 7-methyl-1,4-dioxaspiro[4.4]nonan-6-one 

Relevant academic research and scientific papers

Cyclopentanone Derivatives from 5-Hydroxymethylfurfural via 1-Hydroxyhexane-2,5-dione as Intermediate

An efficient strategy for the conversion of biomass derived 5-hydroxymethylfurfural (HMF) into 2-hydroxy-3-methylcyclopent-2-enone (MCP) by an intramolecular aldol condensation of 1-hydroxyhexane-2,5-dione (HHD) has been developed. Further transformations of MCP towards the diol, enol acetate, levulinic acid and N-heterocyclic compounds are also reported.

SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE

The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.

Process for preparing cyclopentenone derivatives

A process for preparing cyclopentenone derivatives represented by the formula: STR1 wherein R1 is methyl or ethyl, and R2 is hydrogen, methyl or acetyl, characterized in that a 1,4-diketone derivative represented by the formula: wherein R1 and R2 are as defined above is cyclized in the presence of a basic catalyst.